chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My last vaccine shot was on 4/23/21. After the shots I began experiencing some slight chest pains, which I thought must be stress or anxiety related. I didn't think much of it until I experienced an ER visit on 6/18/21 around 11:00 AM. I felt as though I was having a stroke, collapsed at home with dysfunctional motor skills, and was transported by ambulance. I was given fluids and told I should schedule an MRI of the brain due to previously having a blood clot in my brain many, many years ago. I felt it was important to report to you about this issue incase others encounter similar events. I also have not had a menstrual cycle since the end of June. I do have a history of Endometriosis and PCOS however. I did see an article that the UK is investigating that the vaccinations may play a part in delayed menstrual cycles, so I thought I should mention this occurrence. I still encounter slight chest pains at least once a month.
Patient said vaccine hurt and arm still hurt 3-4 hours later after taking TYLENOL. Patient screamed as soon as needle entered her arm. Her muscle was very tense and tight and she pulled away and grabbed my arm while I was pushing in the shot.
p/vax pt exp a breakthrough case of chickenpox w/approx 35 lesions over body & scalp w/no rash;
Child got HPV9 - within minutes and while sister was getting imm -> child got up and fell on her face. Then had a seizure like episode that lasted seconds. Did fall on face and broke 2 incisors.
Felt Nauseated, stomach cramps 10 to 12 minutes after shot.  Pt Admits to eating very spicy Chinese chicken prior to shot.
Pain at the injection site; Hardness at the injection site; Patient reported that when she woke up, she noticed a green color film like mucous and spit it out; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at the injection site), INJECTION SITE INDURATION (Hardness at the injection site) and SECRETION DISCHARGE (Patient reported that when she woke up, she noticed a green color film like mucous and spit it out) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE PAIN (Pain at the injection site), INJECTION SITE INDURATION (Hardness at the injection site) and SECRETION DISCHARGE (Patient reported that when she woke up, she noticed a green color film like mucous and spit it out). At the time of the report, INJECTION SITE PAIN (Pain at the injection site), INJECTION SITE INDURATION (Hardness at the injection site) and SECRETION DISCHARGE (Patient reported that when she woke up, she noticed a green color film like mucous and spit it out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
2 days p/vax pt devel intestinal bleeding;pt hosp for 3 days & tx w/02, IV fluids & IV ATB;pt mom stated that MD believes cause of bleeding may have been intussusception or volvulus;
Patient was given a skin sensitivity test on (L) forearm on 3/22/11 without reaction so Tdap was administered. On 3/23/11 her skin test measured 20mm x 18 mm. Injection site was red blotchy & warm to touch. LIDEX cream was prescribed.
Then somebody else broke out into shingles on the second day; This is a spontaneous report from a contactable consumer. This contactable consumer reported for a patient. A patient with an unspecified gender and age received bnt162b2 (PFIZER-BIOINTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number: unknown) via unknown route of administration on unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medication were not reported. On an unspecified date, it was reported that then somebody else broke out into shingles on the second day. At the time of this report the outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 63-year-old female patient who received SHINGRIX (batch number 5Z5LX, expiry date 30th January 2020). On 30th December 2017, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 31st December 2017, 1 days after receiving SHINGRIX, the patient experienced injection site pain, headache, fatigue and fever. In January 2018, the outcome of the injection site pain, headache, fatigue and fever were recovered/resolved. The reporter considered the injection site pain, headache, fatigue and fever to be probably related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in left arm. The pain described as moderate at injection site. The events resolved 24 hours after presentation.
INFORMED PER RN THAT PT HAD BEEN GIVEN PFIZER AS DOSE #2 INSTEAD OF GETTING MODERNA.  MODERNA WAS GIVEN AS DOSE #1.
Patient went to her doctor for appointment and complained of a knot still on her arm post immunization.  3 months later, she is still having pain at the injection site.  Doctor confirmed the injection was given in the right location, but needed to be reported to the manufacturer.
p/vax pt exp extreme fatigue;approx 25 days later pt exp heavy vaginal bleeding;LoOvral given as tx;vaginal bleeding lasted 4 days & fatigue resolved;
Patient became lightheaded and dizzy.  Patient was placed in seated position on floor and passed out.  Mild muscle spasm/seizure like activity and pharygeal gurgling.  Patient was unresponsive for approximately 2 minutes and regained consciousness  without intervention.  EMS was called and attended to patient.  Sinus rhythm normal, blood pressure 140/82.  Patient placed into an upright seated position, blood pressure remain unchanged.  Patient declined transport to hospital, was observed for several minutes and released on his own volition.
Chills, fever began at 10:30 pm, 3/24/2021. On 3/25/2021, fever over 102.2, nausea, extreme headache, chills, inability to eat or drink, aches, weak, tired.  Fever dropped to 100.2 later in day, headache lessoned ~6 pm after taking one prescription migraine tablet (rizatriptan 5 mg) plus one OTC migraine formula tablet (acetaminophen-250 mg) + (aspirin-250 mg) + (caffeine-65 mg).  Continued with chills, fever, headache, nasea into next day. Gradually subsided. I have had a headache every day since the vaccination.  I wake up with a very bad headache and have taken both my prescription and/or OTC migraine tablets to help reduce the headache. Still weak and tired.  I had COVID-19 in Nov. 2020.
Shaking with chills; Diaphoresis; Stuffy nose; Temperature of 100.4 degrees F; Chills; Feeling delirious; Loss of appetite; Diarrhea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DELIRIUM (Feeling delirious) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: PNEUMOVAX, Spironolactone and TETANUS VACCIN. Past adverse reactions to the above products included Blood dyscrasia with Spironolactone. Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic (cephalosporin) and Reaction to previous exposure to any vaccine. Concomitant products included LEVOTHYROXINE, PANTOPRAZOLE, Vitamin D, OXYCODONE, CHLORZOXAZONE, VILAZODONE HYDROCHLORIDE (VIIBRYD), OXCARBAZEPINE, POTASSIUM, FUROSEMIDE, MONTELUKAST and MIRTAZAPINE for an unknown indication.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-May-2021, the patient experienced DELIRIUM (Feeling delirious) , TREMOR (Shaking with chills), HYPERHIDROSIS (Diaphoresis), NASAL CONGESTION (Stuffy nose), PYREXIA (Temperature of 100.4 degrees F) and CHILLS (Chills). In May 2021, the patient experienced DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea) and FATIGUE (Fatigue). At the time of the report, DELIRIUM (Feeling delirious), DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea), TREMOR (Shaking with chills), HYPERHIDROSIS (Diaphoresis), NASAL CONGESTION (Stuffy nose), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown and PYREXIA (Temperature of 100.4 degrees F) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-May-2021, Body temperature: 102.4 (Inconclusive) Temperature of 100.4 degrees F.         Treatment for the events included acetaminophen and ibuprofen. Action taken with mRNA-1273 in response to the events were not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). At the time of the report, MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown. Not Provided          Treatment drugs were not provided concomitant drugs were not provided
Extreme nausea, hot flashes, dizziness, strange head, fatigue, nasal congestion, sore throat, runny nose, sneezing, sore arm,
Information has been received from a licensed practical nurse (LPN) concerning a 10-year-old female who on 06-Sep-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccination included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) and "PEDAP". Subsequently, on an unspecified date, the patient developed dots that turned into a quarter (25 cents) sized raised rash. The rash started on the shoulders and arms. It spread to her neck, chest and legs. The condition progressed and the patient developed shortness of breath and dizziness which resulted in an Emergency Room visit on 19-Sep-2007. She is still complaining of a sore back and dehydration. No additional information was provided. This is one of several reports from the same source. Additional information has been requested.
Body aches and temp. 99 started 8/7 red, hard, swollen area at injection site (approx 10 cm in circumference and down arm form inj site - started to subside 8/18
About 24 hours after the injection, I had extreme fatigue and difficulty getting out of bed. along with body aches in both arms and a seizure like blank stare and couldn't move my arms and legs for a short time.  Briefly I had shakes in both arms but no fever, chills, or headache. By the next morning the injection arm (left) was achy with no other prominent symptoms.
Following vaccine (received 1/28/2021) on February 2, developed rapid atrial fibrillation at  a rate 140-150 after walking dog at 0430. Persisted and spontaneously converted at hospital after 9 hours and before treatment. Placed on eliquis and told not related.  I also had a red, swollen, painful arm from shoulder to elbow with hard quarter size lump at injection site for 9 days.  On February 25th I received my second dose of moderna, 001A21A at 4 pm.  At approximately 0530 I woke feeling mild chills, and 10 minutes later went back into atrial fibrillation at rate of 140-150 which lasted 5 days before converting spontaneously  but on diltiazem and just prior to cardioversion.  Since then paroxysmal afib for which I now take diltiazem and flecainide.
Pt exp anaphylactic rxn p/recvd 2nd dose Typhoid vax; pt devel SOB, shaking of body, pul edema w/coughing up of foamy blood; transported by ambulance to hosp & admitted; steroids & epi were given to treat this rxn, & pt was on ventilator;
Guest came to pharmacy on 11/1/13 to p/u Rx, had picture of arm on cell phone she had taken of arm post flu vaccine - redness, swelling, whelps, warm to touch, bruising, felt bad - went to Dr. - they felt like topical allergic rxn.
Redness, warmth, elevation of 30mm appearing within 24 hours and disappearing 48 hours later.
Severe chills, uncontrollable shivering, fever about 6 hours after vaccination. Then the next day experienced nausea, headache, mild body aches, mild fever. Aspirin and acetaminophen were taken for the fever. Symptoms has mostly subsided by the morning of April 11th.
Patient was given Moderna Bivalent Booster 0.25mcg not 0.5mcg. Wrong dose given to patient.
Pt. noted itching, burning and discomfort at site of vaccination on back of right arm on 3/4/23. Nurse noted site was reddened and approximately 70 mm in diameter with an area that was firm to touch and was approximately 25 mm in diameter in the center on 3/6/23. Pt. stated on 3/9/23 that area was looking better and no further itching, burning or discomfort noted although "hardened" area in center was still present.
40 minutes after the shots, experienced epigastric pain only no treatment req after 12pm today no more abdominal pain.
Covid vaccine monitoring. Inpatient admitted 8/9/21 with covid. SARS-COVID-19 resulted positive 8/7/21. PT completed Moderna vaccine. Dose 1 received 12/30/20, Lot 025J20A. Dose 2 received 2//27/21, Lot 013L20A.  Per documentation in discharge summary signed 8/13/21, PT discharged home.  Primary diagnosis Acute hypoxic respiratory failure with COVID-19 pneumonia.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 at 19:00 as dose 5 (booster), single (Lot number: GH9697) at the age of 49 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Amputee" (unspecified if ongoing), notes: Other medical conditions: Amputee, Intracranial Pressure, SVT; "Intracranial Pressure" (unspecified if ongoing), notes: Intracranial Pressure; "SVT" (unspecified if ongoing), notes: I have SVT - where it went over 200 even while taking 50mg of metoprolol. Concomitant medication(s) included: METOPROLOL; ACETAZOLAMIDE; FERROUS SULFATE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". The event "treatment of covid-19" required emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Dec2022) Positive, notes: I had a PCR lab test done; (Dec2022) Faintly positive, notes: Was testing very faintly positive; (15Dec2022) positive, notes: also did two at home tests; (15Dec2022) positive, notes: also did two at home tests; (16Dec2022) positive, notes: Lab test came back positive today as well. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Anti-viral details: COVID 19 Treatment with Paxlovid. Treatment start date: 07Dec2022. Treatment stop date: 11Dec2022. Indication: Treatment of COVID-19.
headache; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.
Vaccinated patient admitted to hospital for complications of COVID.  Provider D/C note below:  "Brief Summary of Hospital Stay:  Per HPI, 60yo female, with PMHx T2DM, HTN, histoplasmosis, who presented to the ED with nausea/vomiting. Patient reports that she was going in to get a COVID test. Her symptoms started 1/21. She complains of fever/chills, abdominal pain, cough, decreased appetite, shortness of breath, fatigue, malaise. She also complains of a puritic rash across her body. She notes being around her sick 5yo granddaughter, unsure if she had COVID. She is vaccinated for COVID, and had COVID 11/2020. She also notes having a dental procedure done recently and was placed on Clindamycin. She reports finishing Clindamycin on Wednesday 1/19. She reports smoking occassionally. Denies alcohol use. Denies chest pain, headache, diarrhea, sore throat..   In ED, patient was hypoxic- placed on 6L NC and eventually increased to HFNC due to continued hypoxia. No significant findings on lab work.  CXR- No evidence of acute cardiopulmonary process.   Started on Remdesivir, decadron in ED.    Hospital Course:  1. Acute hypoxic respiratory failure: due to recurrent COVID-19 infection, vaccinated  though not boosted. Initially on HFNC, started on dexamethasone and remdesivir with improvement. Patient ultimately able to completely wean off of supplemental O2.    2. Acute metabolic encephalopathy/agitation: may be related to #1, though exact etiology remain entirely unclear. Resolved.    3. Pruritic rash: suspect due to viral syndrome, possible drug related with recent clindamycin use though pt reports tolerating this in the past. Improved   4. Sinus tachycardia: resolved. Likely due to #1, no evidence of PE on imaging.    5. DM II: A1c 7.2, steroid induced hyperglycemia  - Metformin   6. HTN - ARB   7. MDD - Elavil    8. Migraine headache  - PRN Maxalt    Issues Requiring Follow Up:  - Follow up with PCP"
Patient recieved Kinrix (Dtap-IPV) at well child check amd was walking out to check out and fainted. Was not responding for up to five minutes, patient was unable to stay awake and kept "falling asleep". We were able to monitor her for 1 hour in office until she was once again stable. Patient returned for a follow up visit on 9/5/15 presenting with a rash on torso and swelling of hands and feet. Provider dx her with erythema multiforme follwing a vaccination. At this visit she supplied a urine sample which had hematuria - lab results pending. Patient returned again 9/8/15 for another re check and still had rash, but tested positive for strep throat.
0730 received injection 0500 started n/v. 0912 - checked in for appt. PEPTO tablets given and home care instructions for n/v. Pt also sent home with 24 hour quarters. P states this same event happens every year & pt has not documented. When receives live flu - pt states in bed with illness. Pt reports NOT eating eggs - makes her sick (n/v).
This is a spontaneous report from a contactable healthcare professional (patient). A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231 and expiry date: 30Apr2021), intramuscular on left arm, on 15Jan2021 13:15 at a single dose for COVID-19 immunization. Medical history included allergic to shampoo products and chemicals and vaccine has Peg). Patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported.  The patient experienced severe itching and rash in right arm on the 11th day after vaccine administration on 26Jan2021 16:30. It grew from 3.5 inches to as big as 12 inches going around my arm. Patient had to go to emergency room. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Keflex 500mg 4 times a day and bacrim twice a day was given as treatment. Outcome of the events was recovering. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (Prior use was occasional.). Concurrent medical conditions included Lichen planus since 2015. Concomitant products included VITAMIN D NOS, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and PROGESTERONE for an unknown indication, FOLIC ACID (FOLATE).    On 22-Dec-2020 at 2:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 06-Dec-2020 and the estimated date of delivery was 12-Sep-2021. On 22-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  On 22-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The results of Beta HCG and Progesterone Lab test performed in Dec 2020 and Jan 2021 was unknown. Date of estimated date of conception was 21Dec2020.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 31-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
A short time after receiving the 1st vaccination, the patient started to have arthritis-like symptoms. A few months later a neurologist said she had "Lyme." The patient received two shots and has since had extreme pain in her knees.
swelling;redness; rash; infection:  Treated by Family Doctor. antibiotic Doxycycline, Allegra,Prednisone.  Condition cleared the following day after meds.